Latest News about Merck & Co Inc
Recent news which mentions Merck & Co Inc
From CNBC.com News
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
April 25, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
From CNBC.com News
Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
April 19, 2024
From CNBC.com News
FDA approves Merck's drug for rare, deadly lung condition
March 26, 2024
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
From CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
From CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
From CNBC.com News
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
From CNBC.com News
Cramer's week ahead: Fed meeting, labor report, Big Tech earnings
January 26, 2024
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
From CNBC.com News
Dow goes from 37,000 to 38,000 in just 40 days. A history of the Dow and big round numbers
January 23, 2024
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
January 02, 2024
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
From CNBC.com News
From CNBC.com News
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
December 14, 2023
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
From CNBC.com News
Cramer's Lightning Round: Merck is a buy
October 30, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.